Deadline at Midnight? How Mass Resignations Could Endanger Animal Welfare and Public Health
My Vet Candy My Vet Candy

Deadline at Midnight? How Mass Resignations Could Endanger Animal Welfare and Public Health

A controversial deferred resignation offer, requiring over two million federal employees to decide whether to resign or risk termination, has sparked nationwide concern. Among those affected are more than 3,000 veterinary professionals working for the U.S. Department of Agriculture (USDA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Environmental Protection Agency (EPA).

Read More
Breaking: New Bird Flu Strain Detected in Dairy Cattle—What It Means for the Industry
My Vet Candy My Vet Candy

Breaking: New Bird Flu Strain Detected in Dairy Cattle—What It Means for the Industry

On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle. This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.

Read More
The Growing Threat of Avian Flu: A Battle Farmers Are Struggling to Win
My Vet Candy My Vet Candy

The Growing Threat of Avian Flu: A Battle Farmers Are Struggling to Win

In the spring of 2024, the poultry industry in the United States faced an outbreak of Highly Pathogenic Avian Influenza (HPAI) H5N1 that threatened not only millions of birds but also raised concerns about its growing risk to humans. For farmers like Herbruck, whose Poultry Ranch in Michigan is one of the largest egg producers in the country, the battle against bird flu has become an unrelenting war.

Read More
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
My Vet Candy My Vet Candy

Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain

Since its launch in Europe four years ago, Librela has improved the lives of millions of dogs suffering from OA pain. With nearly 25 million doses1 distributed globally, no individual adverse event sign has been reported at a rate higher than rare, as defined by the European Medicines Agency (EMA) – representing less than 10 occurrences per 10,000 treated animals (where one dose equals one treated animal)2 .

Read More